Related Experiment Video
Updated: Sep 12, 2026

Structure-Guided Design and Development of Novel Cyclophilin A Inhibitors and Ganoderiol-F Derivatives: An In-Silico Approach
Published on: June 23, 2026
Structural basis of Nur77-CypA interaction and cyclosporine A-mediated competitive displacement
Lang Chen1, Jiawen Chen2, Wenkai Zhu2
1State Key Laboratory of Magnetic Resonance Spectroscopy and Imaging, National Center for Magnetic Resonance in Wuhan, Wuhan National Laboratory for Optoelectronics, Innovation Academy for Precision Measurement Science and Technology, Chinese Academy of Sciences, Wuhan, 430074, China; University of Chinese Academy of Sciences, Beijing, 100049, China.
Abstract:
Nuclear receptor Nur77, along with cyclophilin A (CypA) and cyclosporine A (CsA), has been shown to participate in crosstalk of signaling cascades associated with inflammation, apoptosis and metabolic regulation. However, the fundamental molecular mechanism governing their mutual interactions is unclear. Using NMR spectroscopy combined with AI-driven docking, we resolved the Nur77 ligand-binding domain (LBD)-CypA interface. NMR analysis mapped the binding mode, revealing a weak yet specific protein-protein interaction. Integration of experimental results with AI modeling produced a high-confidence complex structural model validated by mutational analysis and expanding investigations through the NR4A family paralogs. Strikingly, CsA does not directly bind Nur77 LBD. Rather, it occupies CypA and competitively displaces Nur77 from the same binding groove, as demonstrated by competition assays. Our findings elucidate the mechanism for the Nur77-CypA interaction and refine CsA's mode of action, with implications for therapeutic development.
Related Concept Videos
Allosteric Proteins-ATCase
Aspartate transcarbamoylase (ATCase) is a cytosolic enzyme that catalyzes the condensation of L-aspartate and carbamoyl phosphate to N-carbamoyl-L-aspartate. This reaction is the first step in pyrimidine biosynthesis. UTP and CTP, the end products of the pyrimidine synthesis pathway,...
Factors Affecting Protein-Drug Binding: Drug Interactions
Displacement interactions can have varying outcomes, ranging from toxicity to virtually...
Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes
Drug Elimination by Renal Route: Tubular Secretion
Pharmacogenetics of Phase II Enzymes: N-acetyltransferase, Thiopurine S-methyltransferase, UDP-glucuronosyltransferase
Basicity of Heterocyclic Aromatic Amines
